WebNov 15, 2024 · Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes … WebGet Biophytis SA (BPTS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
French biotech Biophytis sets terms for $20 million US IPO
WebFeb 15, 2024 · Biophytis has raised a total of $34.3M in funding over 7 rounds. Their latest funding was raised on Nov 22, 2024 from a Post-IPO Debt round. Biophytis is registered under the ticker NASDAQ:BPTS . Their stock opened with $16.75 in its Feb 15, 2024 IPO. Biophytis is funded by 7 investors. Kreos Capital and Atlas Capital Markets are the most ... WebApr 7, 2024 · Biophytis SA announces its non audited financial results for the year ended December 31, 2024, and provides updates on key operational achievements as well as … crypto frog frens
Biophytis will participate in a key Workshop on Functional …
WebOct 31, 2024 · Biophytis Publishes Its Key Financial Figures As at 30 June 2024, Announces a Restatement of the Financial Statements Published As of December 31st, 2024 and Provides an Update on the Operational ... WebApr 7, 2024 · Biophytis SA announces its non audited financial results for the year ended December 31, 2024, and provides updates on key operational achievements as well as perspectives for 2024. ... (USA)in December 2024, in March 2024 Biophytis received approval from the Belgian FAMHP to proceed with its clinical investigation of Sarconeos … WebJul 2, 2024 · Press release. Biophytis appoints a new Chief Medical Officer based in the USA. Paris (France), July 2 nd, 2024, 7.30 am - BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to fight age-related degenerative diseases, today announces the appointment of Doctor … cryptography douglas r. stinson